When was Nimble Science founded?

Nimble Science was founded in 2018 and raised its 1st funding round 5 years after it was founded.

Where is Nimble Science located?

Nimble Science is headquartered in Calgary, Canada. It is registered at 2700, 225 - 6th Avenue SW, CALGARY.

Who is the current CEO of Nimble Science?

Sabina Bruehlmann of Nimble Science. They have also founded 1 company.

How many employees does Nimble Science have?

As of Aug 31, 2026, the latest employee count at Nimble Science is 21.

Is Nimble Science a funded company?

Nimble Science is a funded company, having raised a total of $***** in its 1st and only funding round, a Seed round on Apr 04, 2023.

When was the latest funding round of Nimble Science?

Nimble Science's latest funding was a $***** Seed round on Apr 04, 2023, with participation from 11 investors. Its primary sector is Genomics. Globally, the Genomics sector has seen $2.93B in funding in 2026 to date.

Where does Nimble Science rank among its competitors?

Nimble Science ranks 129th amongst 359 active competitors, of which 121 are funded. It stands 11th in terms of total funding among its competitors. The most recent competitor to raise funding was GenSight Biologics, which secured $1.96M in Mar, 2026.

Who are the top competitors of Nimble Science?

Nimble Science's top competitors include Caris Life Sciences, MedGenome and Geneoscopy. Among them, GenSight Biologics secured the most recent funding round in March, 2026.

Nimble Science - 2026 Company Profile, Team, Funding & Competitors

Company Details

Nimble Science is involved in the development of personalized medicine for gut health. It is also involved in the development of probiotic-based medicine, novel capsule, small intestine sampling tool for diagnosing, and others. The company is involved in gut microorganism sequencing and mapping and collection of the biomarker for developing personalized based medicine.

Website: www.nimblesci.com/
Email ID: *****@nimblesci.com
Phone Number: +1 **********
Registered Address: 2700, 225 - 6th Avenue SW, CALGARY

Key Metrics

Founded Year

2018

Location

Calgary, Canada

Stage

Seed

Total Funding

$2.7M in 1 round

Latest Funding Round

Seed, Apr 04, 2023, $*****

Investors

Fusion Fund & 11 more

Ranked

129^th among 359 active competitors

Employee Count

21 as on Aug 31, 2026

Similar Companies

Caris Life Sciences & 507 more

View Nimble Science's full profile

Nimble Science is associated with 1 legal entity given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Reports
Nimble Science Ltd. CIN: 14700945 , Canada, Active	Jan 23, 2023	-	-	-

Nimble Science has raised a total funding of $2.7M over 1 round. Its latest funding round was a Seed round on Apr 04, 2023 for $*****. 11 investors participated in its latest round. Nimble Science has 11 institutional investors and 1 angel investor.

Here is the list of recent funding rounds of Nimble Science:

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Apr 04, 2023	7186769	Seed	7614993	5107274	6037872	3350904

Access funding benchmarks and valuations. Sign up today!

View details of Nimble Science's funding rounds and investors

The founders of Nimble Science is Sabina Bruehlmann. Sabina Bruehlmann is the CEO of Nimble Science.

Here are the details of Nimble Science's key team members:

Sabina Bruehlmann: Co-Founder & CEO of Nimble Science. They serve on the board of 1 company.
Contact Info: 1 email address

Nimble Science's Board of Directors

Nimble Science's board has 3 active members. Gang Wang, Sabina Bruehlmann and Ivneet Bhullar are independent board members.

Here is the list of Nimble Science's board of directors:

Name	Type	Representing	Status	Duration
Gang Wang	Independent board member	-	Current	3y 8m
hmwjxxd	Independent board member	-	Current	6y 7m
at{ytri	Independent board member	-	Current	7y 2m

View details of Nimble Science's Founder profiles and Board Members

Nimble Science's employee count trend

Nimble Science has 21 employees as of Aug 26. Here is Nimble Science's employee count trend over the years:

Uncover Nimble Science's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Nimble Science include Caris Life Sciences, MedGenome and Geneoscopy. Here is the list of Top 10 competitors of Nimble Science, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Caris Life Sciences 1996, Irving (United States), Public	Developer of panomic disease profiling technologies for cancer precision medicine	$1.23B	Sixth Street, Coatue & 19 others	71/100
2nd	MedGenome 2013, Bengaluru (India), Series E	Provider of DNA sequencing, bioinformatics, and multiomics services	$264M	Novo Holdings, Peak XV Partners & 30 others	70/100
3rd	Geneoscopy 2015, St. Louis (United States), Series C	Developer of non-invasive biomarker tests for colorectal cancer	$219M	LightChain Capital, Cultivation Capital & 18 others	67/100
4th	Intellia Therapeutics 2014, Cambridge (United States), Public	Developer of therapeutics based on CRISPR/Cas9 technology for multiple diseases	$85M	Atlas Venture, Novartis & 10 others	66/100
5th	Deep Genomics 2014, Toronto (Canada), Series C	AI-powered platform for RNA biology to accelerate genetic therapy discovery	$238M	SoftBank Vision Fund, True Ventures & 16 others	62/100
6th	UniQure 1998, Amsterdam (Netherlands), Public	Developer of gene-based therapies for patients with genetic or acquired diseases	$111M	Gilde Healthcare, Advent Life Sciences & 11 others	62/100
7th	Regulus Therapeutics 2007, San Diego (United States), Acquired	Innovative medicines company reimagining medicine to improve and extend people’s lives	$35M	Ionis Pharmaceuticals, Alnylam & 8 others	62/100
8th	GenSight Biologics 2011, Paris (France), Public	Developer of viral vector-based gene therapies for retinal neurodegenerative diseases	$76.6M	Perceptive Advisors, Fidelity Investments ... & 17 others	61/100
9th	Repare Therapeutics 2016, Montreal (Canada), Acquired	Developer of targeted therapies to address the genetic alterations associated with selected tumors	$166M	Versant Ventures, Cowen & 13 others	60/100
10th	Dicerna Pharmaceuticals 2007, Lexington (United States), Acquired	Developer of drugs by using RNA interference technology platform	$106M	RA Capital Management, Domain Associates ... & 18 others	60/100
129th	Nimble Science 2018, Calgary (Canada), Seed	Developer of personalised medicine for gut health	$2.7M	Fusion Fund, Alumni Ventures & 10 others	36/100